Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

5.86
Delayed Data
As of 3:59pm ET
 -0.24 / -3.93%
Today’s Change
4.98
Today|||52-Week Range
10.54
-39.59%
Year-to-Date
The Latest Buzz in Biotech
Dec 06 / MotleyFool.com - Paid Partner Content
Amicus Provides Regulatory Update on Fabry Disease Drug
Nov 29 / Zacks.com - Paid Partner Content
Biotech's Dumbest CEO Moves in 2016
Dec 05 / MotleyFool.com - Paid Partner Content
Why Amicus Therapeutics Shares Are Crashing 21.8% Today
Nov 29 / MotleyFool.com - Paid Partner Content
Biotech Stock Roundup: Actelion Soars on Acquisition Talks, Another Clinical Hold for...
Nov 30 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close6.10
Today’s open5.93
Day’s range5.80 - 6.08
Volume2,251,136
Average volume (3 months)2,378,979
Market cap$868.2M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)-29.03%
Earnings growth (this year)-16.99%
Earnings growth (next 5 years)+38.44%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...-0.15-1.85%
LCILannett Company Inc-1.20-4.91%
ZIOPZIOPHARM Oncology In...-0.35-5.09%
INSMInsmed Inc-0.62-4.73%
Data as of 4:01pm ET, 12/07/2016

Financials

Next reporting dateFebruary 20, 2017
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$132.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John Francis Crowley
President &
Chief Operating Officer
Bradley L. Campbell
Corporate headquarters
Cranbury, New Jersey

Forecasts


Search for Jobs